PBYI | Puma Biotechnology, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	2.8864 - 3.14
52 Week Range	2.2300 - 7.73
Beta	1.56
Implied Volatility	292.03%
IV Rank	20.61%
Day's Volume	536,922
Average Volume	370,387
Shares Outstanding	49,087,700
Market Cap	147,263,100
Sector	Healthcare
Industry	Biotechnology
IPO Date	2012-04-24

Valuation
Profitability
Growth
Health
P/E Ratio	6.38
Forward P/E Ratio	N/A
EPS	0.47
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	185
Country	USA
Website	PBYI

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.

PBYI's peers: RARE, CRNX, ARVN, RVMD, KURA, TSVT, ICPT, IOVA, SRPT, MDGL, VKTX, HEPA, PTCT, HRTX, CHRS, LRMR, MGNX, VERU

*Chart delayed

Analyzing fundamentals for PBYI we got that it has weak fundamentals where Valuation is considered to be fairly valued, Profitability is very poor, Growth is very good and Health is frighteningly weak. For more detailed analysis please see PBYI Fundamentals page.

Watching at PBYI technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on PBYI Technicals page.